Runben Biotechnology Co., Ltd. (SHA:603193)
16.07
-0.82 (-4.85%)
Nov 20, 2026, 3:00 PM CST
| Market Cap | 6.50B -35.5% |
| Revenue (ttm) | 1.71B +12.9% |
| Net Income | 348.54M +14.2% |
| EPS | 0.86 +13.4% |
| Shares Out | 404.59M |
| PE Ratio | 18.67 |
| Forward PE | 17.37 |
| Dividend | 0.54 (3.36%) |
| Ex-Dividend Date | Sep 21, 2026 |
| Volume | 3,382,354 |
| Open | 16.71 |
| Previous Close | 16.89 |
| Day's Range | 15.97 - 16.71 |
| 52-Week Range | 16.02 - 26.78 |
| Beta | 0.35 |
| Analysts | Strong Buy |
| Price Target | 29.85 (+85.75%) |
| Est. Earnings | Apr 23, 2027 |